Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamics and pharmacokinetics of remimazolam besylate in critically ill ICU patients
ChiCTR2100050374Phase 4Recruiting
- Sponsor
- Gansu Provincial People's Hospital
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam, sponsored by Gansu Provincial People's Hospital. Primary endpoints: Blood pressure, Hypotension and 3 more. Started Sep 2021; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2100050374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050374.